Carregant...
Graft-versus-host disease after donor leukocyte infusions: presentation and management
Donor lymphocyte infusion (DLI) is used after both myeloablative and non-myeloablative stem-cell transplantation to treat and prevent relapse, to establish full donor chimerism, and to treat and prevent infections. The major treatment-related complication of DLI is graft-versus-host disease (GVHD)....
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2504712/ https://ncbi.nlm.nih.gov/pubmed/18503987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2008.02.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|